Blinder AR, Sapiro D, Baker JE, Qin Z, Bancos I, Lyden ML, Young WF, Wachtel H, Cohen DL, Kürzinger L, Fassnacht M, Luther JM, Williams TA, Reincke M, Turcu AF, Else T, Giordano TJ, Udager AM, Rainey WE, Nanba K. Adrenal histologic and genetic characteristics of primary aldosteronism in late adulthood. , Eur J Endocrinol. : 2026
White WB, Azizi M, Ferdinand K, Cohen DL, Nührenberg T, Lefkowitz M, Jiao R, Rizkala AR, Maboudian M, Williams B. Natriuretic Peptide Receptor-1 Agonist for Resistant Hypertension: A Randomized Phase 2 Trial. , J Am Coll Cardiol. 2026 Jan 13:S0735-1097(25)10351-3. doi: 10.1016/j.jacc.2025.11.045. Epub ahead of print. PMID: 41563174., S0735-1097(25): 2026,10351-10353
Pregnall AM, Wubbenhorst B, D'Andrea K, Pluta J, Amjad W, Shilan J, Cohen DL, Weathers B, Bennett B, Bonanni M, Montone K, Nathanson KL, Wachtel H. Metastatic progression of pheochromocytoma and paraganglioma occurs via parallel evolution. , NPJ Precis Oncol. : 2026
Estrella MM, Ballew SH, Sang Y, Grams ME, Coresh J, Surapaneni A, Alencar de Pinho N, Ärnlöv J, Brenner H, Carrero JJ, Chen TK, Cohen DL, Cushman M, Gansevoort RT, Hwang SJ, Inker LA, Ix JH, Kabasawa K, Konta T, Lees JS, Polkinghorne KR, Shlipak MG, Vernooij RWM, Wheeler DC, Yadav AK, Levey AS, Eckardt KU; Chronic Kidney Disease Prognosis Consortium Investigators and Collaborators. Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis. , JAMA. , 334(21): 2025,1915-1926
Tasdighi E, Yao Z, Dardari ZA, Jha KK, Osuji N, Rajan T, Boakye E, Matsushita K, Simonsick EM, Lima JAC, Lloyd-Jones DM, Cohen DL, Appel LJ, Khera A, Hall ME, Rodriguez CJ, Judd S, Cole SA, Ramachandran VS, Benjamin EJ, Lotufo PA, Bittencourt MS, El Khoudary SR, Thurston RC, Derby CA, Psaty BM, Eaton CB, LaMonte MJ, Cawthon PM, Orwoll ES, Bhatnagar A, DeFilippis AP, Blaha MJ. Association between cigarette smoking status, intensity, and cessation duration with long-term incidence of nine cardiovascular and mortality outcomes: The Cross-Cohort Collaboration (CCC). , PLoS Med. , 22(11): 2025,e1004561
Shulman R, Yang W, Cohen DL, Reese PP, Cohen JB; CRIC Study Investigators. Renin-Angiotensin System Inhibitors in Patients With Nonproteinuric Chronic Kidney Disease and Kidney Outcomes: Findings From the CRIC Study. , Kidney Med. , 8(1): 2025,101159
van Rooyen D, Bandulik S, Coon GA, Laukemper M, Kumar-Sinha C, Udager AM, Lerario AM, Lee C, Wachtel H, Cohen DL, Luther JM, Giordano TJ, Scholl UI, Butz F, Popp B, Turcu AF, Warth R, Rainey WE, Rege J. Somatic Mutations in MCOLN3 Are Associated With Aldosterone-Producing Adenomas. , Hypertension. : 2025
Byfield RL, Zhang R, Cohen DL, Townsend R, Hossain A, Shimbo D, Cohen JB; CRIC Study Investigators. Ambulatory Blood Pressure Variability, Progression of Kidney Disease, and Cardiovascular Outcomes in the Chronic Renal Insufficiency Cohort. , Am J Hypertens
: 2025
McCoy IE, Yang J, Go AS, Rincon-Choles H, Taliercio J, Rosas SE, Unruh M, Shah V, Cohen DL, He J, Chen J, Sondheimer J, Parsa A, Yang W, Rao PS, Hsu CY; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Complex Etiologies of the Discordance Between Cystatin C- and Creatinine-Based Estimated GFR and Its Adverse Associations: Findings From the CRIC Study. , Am J Kidney Dis, 13: 2025
Laffin LJ, Kopjar B, Melgaard C, Wolski K, Ibbitson J, Bhikam S, Weir MR, Ofili EO, Mehra R, Luther JM, Cohen DL, Sarraju A, Wilkinson MJ, Flack JM, Rodman D, Nissen SE; Advance-HTN Investigators. Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension. , N Engl J Med. , 392(18): 2025,1813-1823
